{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:08:03Z","timestamp":1767899283321,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05198-x","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:03:13Z","timestamp":1764817393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and pharmacological characterization of a natural folipastatin as a CFTR inhibitor and potential anti-secretory agent in a human colonoid model"],"prefix":"10.1186","volume":"26","author":[{"given":"Saravut","family":"Satitsri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rungtiwa","family":"Khumjiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichakorn","family":"Worakajit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodee","family":"Nutho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanyada","family":"Rungrotmongkol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patima","family":"Phainuphong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taya","family":"Kitiyakara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vatcharin","family":"Rukachaisirikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatchai","family":"Muanprasat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"1","key":"5198_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/gmic.1.1.11036","volume":"1","author":"K Hodges","year":"2010","unstructured":"Hodges K, Gill R. Infectious diarrhea: cellular and molecular mechanisms. Gut Microbes. 2010;1(1):4\u201321.","journal-title":"Gut Microbes"},{"issue":"11","key":"5198_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","volume":"18","author":"GBDDD Collaborators","year":"2018","unstructured":"Collaborators GBDDD. Estimates of the global, regional, and National morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1211\u201328.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5198_CR3","doi-asserted-by":"publisher","first-page":"G405","DOI":"10.1152\/ajpgi.00316.2021","volume":"322","author":"SJ Keely","year":"2022","unstructured":"Keely SJ, Barrett KE. Intestinal secretory mechanisms and diarrhea. Am J Physiol Gastrointest Liver Physiol. 2022;322(4):G405\u201320.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"5198_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.4155\/fmc.13.42","volume":"5","author":"C Muanprasat","year":"2013","unstructured":"Muanprasat C, Chatsudthipong V. Cholera: pathophysiology and emerging therapeutic targets. Future Med Chem. 2013;5(7):781\u201398.","journal-title":"Future Med Chem"},{"issue":"11","key":"5198_CR5","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI0216112","volume":"110","author":"T Ma","year":"2002","unstructured":"Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002;110(11):1651\u20138.","journal-title":"J Clin Invest"},{"issue":"2","key":"5198_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1085\/jgp.200409059","volume":"124","author":"C Muanprasat","year":"2004","unstructured":"Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, Verkman AS. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol. 2004;124(2):125\u201337.","journal-title":"J Gen Physiol"},{"issue":"4","key":"5198_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1124\/mol.115.098368","volume":"88","author":"Y Kim","year":"2015","unstructured":"Kim Y, Anderson MO, Park J, Lee MG, Namkung W, Verkman AS. Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 inhibits CFTR chloride channel gating by competition with ATP. Mol Pharmacol. 2015;88(4):689\u201396.","journal-title":"Mol Pharmacol"},{"key":"5198_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.phrs.2015.08.012","volume":"100","author":"P Pongkorpsakol","year":"2015","unstructured":"Pongkorpsakol P, Wongkrasant P, Kumpun S, Chatsudthipong V, Muanprasat C. Inhibition of intestinal chloride secretion by piperine as a cellular basis for the anti-secretory effect of black peppers. Pharmacol Res. 2015;100:271\u201380.","journal-title":"Pharmacol Res"},{"key":"5198_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bcp.2018.02.024","volume":"150","author":"P Muangnil","year":"2018","unstructured":"Muangnil P, Satitsri S, Tadpetch K, Saparpakorn P, Chatsudthipong V, Hannongbua S, et al. A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheas. Biochem Pharmacol. 2018;150:293\u2013304.","journal-title":"Biochem Pharmacol"},{"key":"5198_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173393","volume":"885","author":"N Akrimajirachoote","year":"2020","unstructured":"Akrimajirachoote N, Satitsri S, Sommart U, Rukachaisirikul V, Muanprasat C. Inhibition of CFTR-mediated intestinal chloride secretion by a fungus-derived arthropsolide A: mechanism of action and anti-diarrheal efficacy. Eur J Pharmacol. 2020;885:173393.","journal-title":"Eur J Pharmacol"},{"key":"5198_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phymed.2017.04.001","volume":"29","author":"P Bellio","year":"2017","unstructured":"Bellio P, Di Pietro L, Mancini A, Piovano M, Nicoletti M, Brisdelli F, et al. SOS response in bacteria: inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein. Phytomedicine. 2017;29:11\u20138.","journal-title":"Phytomedicine"},{"key":"5198_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24173202","author":"R Dongmo Zeukang","year":"2019","unstructured":"Dongmo Zeukang R, Siwe-Noundou X, Tagatsing Fotsing M, Tabopda Kuiate T, Mbafor JT, Krause RWM, et al. Cordidepsine is a potential new anti-HIV depsidone from Cordia millenii, Baker. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24173202.","journal-title":"Molecules"},{"issue":"5","key":"5198_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.phymed.2009.07.018","volume":"17","author":"NK Honda","year":"2010","unstructured":"Honda NK, Pavan FR, Coelho RG, de Andrade Leite SR, Micheletti AC, Lopes TI, et al. Antimycobacterial activity of lichen substances. Phytomedicine. 2010;17(5):328\u201332.","journal-title":"Phytomedicine"},{"issue":"6","key":"5198_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3109\/08923973.2013.834930","volume":"35","author":"FB Okoye","year":"2013","unstructured":"Okoye FB, Nworu CS, Akah PA, Esimone CO, Debbab A, Proksch P. Inhibition of inflammatory mediators and reactive oxygen and nitrogen species by some depsidones and diaryl ether derivatives isolated from Corynespora cassiicola, an endophytic fungus of Gongronema latifolium leaves. Immunopharmacol Immunotoxicol. 2013;35(6):662\u20138.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"8","key":"5198_CR15","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.7164\/antibiotics.45.1195","volume":"45","author":"K Hamano","year":"1992","unstructured":"Hamano K, Kinoshita-Okami M, Hemmi A, Sato A, Hisamoto M, Matsuda K, et al. Folipastatin, a new depsidone compound from Aspergillus unguis as an inhibitor of phospholipase A2. Taxonomy, fermentation, isolation, structure determination and biological properties. J Antibiot (Tokyo). 1992;45(8):1195\u2013201.","journal-title":"J Antibiot (Tokyo)"},{"issue":"39","key":"5198_CR16","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1016\/j.tet.2018.07.059","volume":"74","author":"P Phainuphong","year":"2018","unstructured":"Phainuphong P, Rukachaisirikul V, Phongpaichit S, Sakayaroj J, Kanjanasirirat P, Borwornpinyo S, et al. Depsides and depsidones from the soil-derived fungus Aspergillus Unguis PSU-RSPG204. Tetrahedron. 2018;74(39):5691\u20139.","journal-title":"Tetrahedron"},{"issue":"1","key":"5198_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","volume":"16","author":"H Gehart","year":"2019","unstructured":"Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16(1):19\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"5198_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jcmgh.2015.10.001","volume":"2","author":"J In","year":"2016","unstructured":"In J, Foulke-Abel J, Zachos NC, Hansen AM, Kaper JB, Bernstein HD, et al. Enterohemorrhagic Escherichia coli reduce mucus and intermicrovillar bridges in human stem cell-derived colonoids. Cell Mol Gastroenterol Hepatol. 2016;2(1):48\u2013e623.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"5198_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1096\/fj.201600891R","volume":"31","author":"O Cil","year":"2017","unstructured":"Cil O, Phuan PW, Gillespie AM, Lee S, Tradtrantip L, Yin J, et al. Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins. FASEB J. 2017;31(2):751\u201360.","journal-title":"FASEB J"},{"issue":"7","key":"5198_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm.3201","volume":"19","author":"JF Dekkers","year":"2013","unstructured":"Dekkers JF, Wiegerinck CL, de Jonge HR, Bronsveld I, Janssens HM, de Winter-de Groot KM, et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat Med. 2013;19(7):939\u201345.","journal-title":"Nat Med"},{"issue":"15","key":"5198_CR21","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1016\/j.bmc.2018.07.036","volume":"26","author":"P Phainuphong","year":"2018","unstructured":"Phainuphong P, Rukachaisirikul V, Saithong S, Phongpaichit S, Sakayaroj J, Srimaroeng C, et al. Asperidines A-C, pyrrolidine and piperidine derivatives from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178. Bioorg Med Chem. 2018;26(15):4502\u20138.","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"5198_CR22","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.gastro.2015.11.047","volume":"150","author":"J Foulke-Abel","year":"2016","unstructured":"Foulke-Abel J, In J, Yin J, Zachos NC, Kovbasnjuk O, Estes MK, et al. Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology. Gastroenterology. 2016;150(3):638\u201349. e8.","journal-title":"Gastroenterology"},{"issue":"7","key":"5198_CR23","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00018-014-1749-2","volume":"72","author":"JP Mornon","year":"2015","unstructured":"Mornon JP, Hoffmann B, Jonic S, Lehn P, Callebaut I. Full-open and closed CFTR channels, with lateral tunnels from the cytoplasm and an alternative position of the F508 region, as revealed by molecular dynamics. Cell Mol Life Sci. 2015;72(7):1377\u2013403.","journal-title":"Cell Mol Life Sci"},{"issue":"18","key":"5198_CR24","doi-asserted-by":"publisher","first-page":"15419","DOI":"10.1074\/jbc.M111713200","volume":"277","author":"L Aleksandrov","year":"2002","unstructured":"Aleksandrov L, Aleksandrov AA, Chang XB, Riordan JR. The first nucleotide binding domain of cystic fibrosis transmembrane conductance regulator is a site of stable nucleotide interaction, whereas the second is a site of rapid turnover. J Biol Chem. 2002;277(18):15419\u201325.","journal-title":"J Biol Chem"},{"issue":"3","key":"5198_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1085\/jgp.200308798","volume":"122","author":"C Basso","year":"2003","unstructured":"Basso C, Vergani P, Nairn AC, Gadsby DC. Prolonged nonhydrolytic interaction of nucleotide with cftr\u2019s NH2-terminal nucleotide binding domain and its role in channel gating. J Gen Physiol. 2003;122(3):333\u201348.","journal-title":"J Gen Physiol"},{"issue":"3","key":"5198_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2017.06.041","volume":"170","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Liu F, Chen J. Conformational changes of CFTR upon phosphorylation and ATP binding. Cell. 2017;170(3):483\u201391. e8.","journal-title":"Cell"},{"key":"5198_CR27","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, et al. Gaussian 09. Wallingford: Gaussian Inc; 2009."},{"issue":"1","key":"5198_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, et al. UCSF chimerax: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70\u201382.","journal-title":"Protein Sci"},{"issue":"6387","key":"5198_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/358581a0","volume":"358","author":"M Egan","year":"1992","unstructured":"Egan M, Flotte T, Afione S, Solow R, Zeitlin PL, Carter BJ, Guggino WB. Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR. Nature. 1992;358(6387):581\u20134.","journal-title":"Nature"},{"issue":"8","key":"5198_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrgastro.2015.111","volume":"12","author":"JR Thiagarajah","year":"2015","unstructured":"Thiagarajah JR, Donowitz M, Verkman AS. Secretory diarrhoea: mechanisms and emerging therapies. Nat Rev Gastroenterol Hepatol. 2015;12(8):446\u201357.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"5198_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1165\/ajrcmb.13.6.7576703","volume":"13","author":"TJ Kelley","year":"1995","unstructured":"Kelley TJ, al-Nakkash L, Drumm ML. CFTR-mediated chloride permeability is regulated by type III phosphodiesterases in airway epithelial cells. Am J Respir Cell Mol Biol. 1995;13(6):657\u201364.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"5198_CR32","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1074\/jbc.M806780200","volume":"284","author":"P Kongsuphol","year":"2009","unstructured":"Kongsuphol P, Cassidy D, Hieke B, Treharne KJ, Schreiber R, Mehta A, Kunzelmann K. Mechanistic insight into control of CFTR by AMPK. J Biol Chem. 2009;284(9):5645\u201353.","journal-title":"J Biol Chem"},{"issue":"20","key":"5198_CR33","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.1073\/pnas.94.20.11055","volume":"94","author":"SM Travis","year":"1997","unstructured":"Travis SM, Berger HA, Welsh MJ. Protein phosphatase 2\u00a0C dephosphorylates and inactivates cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A. 1997;94(20):11055\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5198_CR34","first-page":"L305","volume":"274","author":"HA Berger","year":"1998","unstructured":"Berger HA, Travis SM, Welsh MJ. Fluoride stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity. Am J Physiol. 1998;274(3):L305\u201312.","journal-title":"Am J Physiol"},{"issue":"11","key":"5198_CR35","first-page":"738","volume":"92","author":"J Mayol","year":"2000","unstructured":"Mayol J, Alarma-Estrany P, Adame Y, Alvarez Fernandez-Represa J. Effects of a tyrosine phosphatase inhibitor on chloride secretion in human intestinal epithelia. Rev Esp Enferm Dig. 2000;92(11):738\u201347.","journal-title":"Rev Esp Enferm Dig"},{"issue":"3","key":"5198_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bcp.2015.05.016","volume":"96","author":"C Muanprasat","year":"2015","unstructured":"Muanprasat C, Wongkrasant P, Satitsri S, Moonwiriyakit A, Pongkorpsakol P, Mattaveewong T, et al. Activation of AMPK by chitosan oligosaccharide in intestinal epithelial cells: mechanism of action and potential applications in intestinal disorders. Biochem Pharmacol. 2015;96(3):225\u201336.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"5198_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0287-2","volume":"51","author":"B Lee","year":"2019","unstructured":"Lee B, Hong GS, Lee SH, Kim H, Kim A, Hwang EM, et al. Anoctamin 1\/TMEM16A controls intestinal Cl(-) secretion induced by carbachol and cholera toxin. Exp Mol Med. 2019;51(8):1\u201314.","journal-title":"Exp Mol Med"},{"issue":"50","key":"5198_CR38","doi-asserted-by":"publisher","first-page":"12757","DOI":"10.1073\/pnas.1815287115","volume":"115","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Liu F, Chen J. Molecular structure of the ATP-bound, phosphorylated human CFTR. Proc Natl Acad Sci U S A. 2018;115(50):12757\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5198_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12917-022-03536-6","volume":"19","author":"S Satitsri","year":"2023","unstructured":"Satitsri S, Akrimajirachoote N, Nunta K, Ruennarong N, Amnucksoradej O, Muanprasat C. Piperine as potential therapy of post-weaning Porcine diarrheas: an in vitro study using a Porcine duodenal enteroid model. BMC Vet Res. 2023;19(1):4.","journal-title":"BMC Vet Res"},{"issue":"10","key":"5198_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2174\/1381612053507521","volume":"11","author":"MC Meyer","year":"2005","unstructured":"Meyer MC, Rastogi P, Beckett CS, McHowat J. Phospholipase A2 inhibitors as potential anti-inflammatory agents. Curr Pharm Des. 2005;11(10):1301\u201312.","journal-title":"Curr Pharm Des"},{"issue":"14","key":"5198_CR41","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.jmb.2016.05.016","volume":"428","author":"G Faure","year":"2016","unstructured":"Faure G, Bakouh N, Lourdel S, Odolczyk N, Premchandar A, Servel N, et al. Rattlesnake phospholipase A2 increases CFTR-chloride channel current and corrects \u2206F508CFTR dysfunction: impact in cystic fibrosis. J Mol Biol. 2016;428(14):2898\u2013915.","journal-title":"J Mol Biol"},{"issue":"7","key":"5198_CR42","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/jat.1348","volume":"28","author":"AA Lima","year":"2008","unstructured":"Lima AA, Nascimento NR, Fang GD, Yotseff P, Toyama MH, Guerrant RL, et al. Role of phospholipase A2 and tyrosine kinase in clostridium difficile toxin A-induced disruption of epithelial integrity, histologic inflammatory damage and intestinal secretion. J Appl Toxicol. 2008;28(7):849\u201357.","journal-title":"J Appl Toxicol"},{"key":"5198_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejphar.2017.01.026","volume":"798","author":"P Pongkorpsakol","year":"2017","unstructured":"Pongkorpsakol P, Satitsri S, Wongkrasant P, Chittavanich P, Kittayaruksakul S, Srimanote P, et al. Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of vibrio cholerae infection through NF-kappaB Inhibition and AMPK activation. Eur J Pharmacol. 2017;798:94\u2013104.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"5198_CR44","doi-asserted-by":"publisher","first-page":"e0010989","DOI":"10.1371\/journal.pntd.0010989","volume":"16","author":"R Noitem","year":"2022","unstructured":"Noitem R, Pongkorpsakol P, Changsen C, Sukpondma Y, Tansakul C, Rukachaisirikul V, et al. Natural statin derivatives as potential therapy to reduce intestinal fluid loss in cholera. PLoS Negl Trop Dis. 2022;16(12):e0010989.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"5198_CR45","doi-asserted-by":"publisher","first-page":"e0009969","DOI":"10.1371\/journal.pntd.0009969","volume":"15","author":"R Erdem","year":"2021","unstructured":"Erdem R, Ambler G, Al-Ibrahim M, Fraczek K, Dong SD, Gast C, et al. A phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model. PLoS Negl Trop Dis. 2021;15(11):e0009969.","journal-title":"PLoS Negl Trop Dis"},{"key":"5198_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111583","volume":"139","author":"C Yimnual","year":"2021","unstructured":"Yimnual C, Satitsri S, Ningsih BNS, Rukachaisirikul V, Muanprasat C. A fungus-derived purpactin A as an inhibitor of TMEM16A chloride channels and mucin secretion in airway epithelial cells. Biomed Pharmacother. 2021;139:111583.","journal-title":"Biomed Pharmacother"},{"issue":"7083","key":"5198_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature04712","volume":"440","author":"DC Gadsby","year":"2006","unstructured":"Gadsby DC, Vergani P, Csanady L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature. 2006;440(7083):477\u201383.","journal-title":"Nature"},{"issue":"2","key":"5198_CR48","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sj.emboj.7600040","volume":"23","author":"HA Lewis","year":"2004","unstructured":"Lewis HA, Buchanan SG, Burley SK, Conners K, Dickey M, Dorwart M, et al. Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 2004;23(2):282\u201393.","journal-title":"EMBO J"},{"issue":"6","key":"5198_CR49","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1124\/mol.112.080267","volume":"82","author":"Y Norimatsu","year":"2012","unstructured":"Norimatsu Y, Ivetac A, Alexander C, O\u2019Donnell N, Frye L, Sansom MS, Dawson DC. Locating a plausible binding site for an open-channel blocker, GlyH-101, in the pore of the cystic fibrosis transmembrane conductance regulator. Mol Pharmacol. 2012;82(6):1042\u201355.","journal-title":"Mol Pharmacol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05198-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05198-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05198-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:03:36Z","timestamp":1767884616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-025-05198-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5198"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05198-x","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Human Research Ethics Committee of the Faculty of Medicine Ramathibodi Hospital, Mahidol University (permit number MURA2024\/212) in full compliance with International Guidelines for Human Research Protection such as Declaration of Helsinki, The Belmont Report, CIOMS Guidelines and the International Conference on Harmonization in Good Clinical Practice (ICH-GCP).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}